Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Registry Study of Patients Initiating Pharmacologic Therapy for Overactive Bladder in Taiwan, Korea and China

NCT03572231 is registered in ClinicalTrials.gov with Astellas Pharma Singapore Pte. Ltd. as lead sponsor.

NCT NCT03572231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03572231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Registry Study of Patients Initiating Pharmacologic Therapy for Overactive Bladder in Taiwan, Korea and China
Lead sponsor
Astellas Pharma Singapore Pte. Ltd.
Phase
Observational
Overall status
Completed
Start date
July 19, 2018
Completion date
March 30, 2020
Enrollment
805 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder (oab)